SLNSW-Avelumab, an anti-PD-L1 antibody, in patients wit...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Full title: Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Author/creator: Dirix, Luc Y., Takacs, Istvan, Jerusalem, Guy, Nikolinakos, Petros, Arkenau, Hendrik-Tobias, Forero-Torres, Andres, Boccia, Ralph, Lippman, Marc E., Somer, Robert, Smakal, Martin, Emens, Leisha A., Hrinczenko, Borys, Edenfield, William, Gurtler, Jayne, von Heydebreck, Anja, Grote, Hans Juergen, Chin, Kevin, Hamilton, Erika P..

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

Language: English

Formats: Articles

Publishers: New York: Springer US

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    Share

    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

    Full title

    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

    Author / Creator

    Dirix, Luc Y. ; Takacs, Istvan ; Jerusalem, Guy ; Nikolinakos, Petros ; Arkenau, Hendrik-Tobias ; Forero-Torres, Andres ; Boccia, Ralph ; Lippman, Marc E. ; Somer, Robert ; Smakal, Martin ; Emens, Leisha A. ; Hrinczenko, Borys ; Edenfield, William ; Gurtler, Jayne ; von Heydebreck, Anja ; Grote, Hans Juergen ; Chin, Kevin ; Hamilton, Erika P.

    Publisher

    New York: Springer US

    Journal title

    Breast cancer research and treatment, 2018, Vol.167 (3), p.671-686

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Antibodies Antibodies, Anti-Idiotypic - administration & dosage Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antitumor activity Apoptosis Avelumab B7-H1 Antigen - antagonists & inhibitors B7-H1 Antigen - genetics B7-H1 Antigen - immunology Breast cancer Cancer Care and treatment Clinical Trial Disease-Free Survival Female Gene Expression Regulation, Neoplastic - drug effects Human health sciences Humans Immunohistochemistry Immunotherapy Medicine Medicine & Public Health Metastases Metastasis Metastatic breast cancer Middle Aged Monoclonal antibodies Neoplasm Metastasis Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - pathology Oncologie Oncology Oncology, Experimental PD-1 protein PD-L1 PD-L1 protein Sciences de la santé humaine Second-line Solid tumors Targeted cancer therapy Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - genetics Triple Negative Breast Neoplasms - pathology Triple-negative breast cancer Viral antibodies

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807460

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections